ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
5 hedge funds and large institutions have $468K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$136K |
2 |
Morgan Stanley
New York
|
$13K |
3 |
CG
Cutler Group
San Francisco,
California
|
$5K |
Top Sellers
1 |
Jane Street
New York
|
$0 |
2 |
VF
Virtu Financial
New York
|
$0 |
3 |
UBS Group
Zurich,
Switzerland
|
$28K |
4 |
Citadel Advisors
Miami,
Florida
|
$286K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
$0 |